COMMUNIQUÉS West-GlobeNewswire

Family Insight Appoints Kyle Williamson as Vice President of Business Development, Accelerates Expansion and Partnerships in Value-Based Care
19/02/2026
RICHMOND, Va., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Family Insight, PC , a Whitecap Care, LLC company and a leader in value-based care (VBC) and behavioral health, announces the appointment of Kyle Williamson as vice [...]
Human Appeal reaches over 862,000 people with food, water and life-saving emergency response amid ongoing Sudan conflict
19/02/2026
The humanitarian charity has made efforts to provide food parcels, hot school meals and assist with clean water supply across Sudan during the ongoing conflict which is driving mass displacement MISSION VIEJO, Calif., [...]
Klothea Bio Announces the Launch of a Phase 1b Clinical Trial of AKL003, an Alpha Klotho mRNA Therapeutic, for the Extension of Human Lifespan
19/02/2026
MIAMI, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Klothea Bio, Inc. (“Klothea Bio”), a clinical-stage biotechnology company developing therapeutics based on their proprietary serum klotho platform, today announced the launch of [...]
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
19/02/2026
Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry SALT LAKE CITY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic [...]
Mapi Pharma to Host Virtual KOL Event to Discuss Glatiramer Acetate Once a Month Depot for Primary Progressive Multiple Sclerosis, on March 3, 2026
19/02/2026
NESS ZIONA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable [...]
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
19/02/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced Chief Executive Officer Michael Castagna, PharmD is scheduled to present and share [...]
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
19/02/2026
SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
19/02/2026
Omada for Cholesterol closes a critical gap in cardiovascular care, delivering between-visit support for the many adults whose LDL remains uncontrolled under usual care¹ SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- [...]
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
19/02/2026
Company Ready to Scale Growth through OneTest™ AI-Powered Blood Tests for Cancer and Longevity GAITHERSBURG, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market leader in cutting- [...]
Cynet Releases 2H 2025 CyOps ECHO Report: AI-Driven Attacks and “Cyber Cartels" Collapse Exploitation Window to Hours
19/02/2026
Frontline incident responders document how adversaries are shifting from breaking security controls to abusing them as designed BOSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cynet , the unified, AI-powered cybersecurity [...]
Outlook Therapeutics Expands European Footprint with Exclusive Commercial Distribution Agreement with Mediconsult AG for LYTENAVA™ (bevacizumab gamma) in Switzerland
19/02/2026
Veteran ophthalmology leader with 35+ years of market expertise selected as exclusive Switzerland partner Mediconsult to seek Marketing Authorization and lead commercialization activities for LYTENAVA™ (bevacizumab [...]
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
19/02/2026
Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular Space HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. ( [...]
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
19/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat [...]
Dror Ortho-Design Receives 510(k) FDA Clearance for Next-Generation Smile Correction Solution
19/02/2026
FDA clearance paves the way for U.S. commercial launch of innovative alternative to traditional aligners JERUSALEM, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), a [...]
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
19/02/2026
AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Biotechnology mergers and acquisitions (M&As) are increasingly shaped by a clear strategic evolution. Pharmaceutical companies are [...]
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
19/02/2026
With strong underlying market demand, European distributor and expert physician customer purchase orders are being received by the Company as its 2026 revenue guidance range increases to $1.5 million - $3 million [...]
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
19/02/2026
MIAMI, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”
19/02/2026
Strategic Transaction Advances Company’s Growth SARASOTA, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment [...]
Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth
19/02/2026
Upfront Cash, Equity Participation and Tiered Royalty Structure Providing Long-Term Revenue Upside FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced [...]

Pages